Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines

<p>Abstract</p> <p>Purpose</p> <p>Myocardial late gadolinium enhancement was originally validated using higher than label-recommended doses of gadolinium chelate. The objective of this study was to evaluate available evidence for various gadolinium dosing regimens used...

Full description

Bibliographic Details
Main Authors: Nacif Marcelo S, Arai Andrew A, Lima Joao AC, Bluemke David A
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Journal of Cardiovascular Magnetic Resonance
Subjects:
Online Access:http://www.jcmr-online.com/content/14/1/18